Skip to main content

BioXcel Therapeutics shares pop after audit of Alzheimer’s trial data

Audit findings support application for approval of treatment for Alzheimer's-related agitation, company says
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.